RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
VMGMX
Price
$103.68
Change
+$0.12 (+0.12%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs VMGMX

Header iconRPTIX vs VMGMX Comparison
Open Charts RPTIX vs VMGMXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Growth Index Admiral
Price$103.68
Change+$0.12 (+0.12%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs VMGMX Comparison Chart
Loading...
VS
RPTIX vs. VMGMX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and VMGMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. VMGMX (25.8B). VMGMX pays higher dividends than RPTIX: VMGMX (0.68) vs RPTIX (0.18). RPTIX was incepted earlier than VMGMX: RPTIX (9 years) vs VMGMX (13 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. VMGMX (14.00). VMGMX has a lower initial minimum investment than RPTIX: VMGMX (3000) vs RPTIX (500000). VMGMX annual gain was more profitable for investors over the last year : 24.58 vs. RPTIX (14.81). VMGMX return over 5 years is better than : 61.64 vs. RPTIX (15.09).
RPTIXVMGMXRPTIX / VMGMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD9.1279.75894%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B25.8B122%
Annual Yield % from dividends0.180.6827%
Returns for 1 year14.8124.5860%
Returns for 3 years-13.57-0.642,129%
Returns for 5 years15.0961.6424%
Returns for 10 yearsN/A154.31-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp